Iliac venous outflow obstruction has an important role in the expression of symptomatic chronic venous insufficiency. This anatomic obstruction is frequently overlooked, owing in part to diagnostic ...

For women with subsequent pregnancy, iliac vein stents demonstrate good peripregnancy and postpregnancy stent patency, according to a study published online in the March 1 issue of the Journal of ...

LAS VEGAS, NV—A self-expanding nitinol stent is effective for the treatment of venous obstructions in the iliac and femoral veins, according to 12-month data from the nonrandomized, multicenter ...

Narrowing or blockage of your veins is the principal cause of this problem, which can be life threatening. Fortunately, there is a relatively quick, safe, and effective way to treat this condition by ...

The GORE® VIABAHN® FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and compression resistance for treating a broad range of patients. FLAGSTAFF, Ariz., Jan. 6, 2026 ...

Abre (Medtronic), a dedicated venous stent, has a 12-month primary patency rate of 88%, exceeding the performance goal for effectiveness in its pivotal investigational device exemption (IDE) trial.

Veniti, a Missouri-based company focused on the treatment of venous disease, announced the first successful treatment of a patient with postthrombotic syndrome associated with venous outflow ...

The investigational device evaluated in the trial, previously known as the GORE ® VIAFORT Vascular Stent, will now be referred to as the GORE ® VIABAHN ® FORTEGRA Venous Stent. CAUTION: ...

Although the formation of collaterals is classically regarded as a compensatory mechanism to bypass and thus alleviate an obstruction, the mechanism and inducement of collateral formation are unknown.

The MarketWatch News Department was not involved in the creation of this content. The GORE(R) VIABAHN(R) FORTEGRA Venous Stent is engineered to offer an optimal balance of conformability and ...